Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-06

AUTHORS

H.-Y. Dong, J. Xie, L.-H. Chen, T.-T. Wang, Y.-R. Zhao, Y.-L. Dong

ABSTRACT

To investigate the risk factors associated with the development of thrombocytopenia, and define the thresholds of efficacy and safety in critically ill patients who received linezolid therapy. A retrospective study was performed in critically ill patients treated with linezolid. Risk factors associated with thrombocytopenia were identified via medical records and trough levels (C(min)) measured during linezolid treatment. By establishing a logistic model, the risks were predicted by the receiver operating characteristic (ROC) curve and the thresholds of efficacy and safety were identified in the patients. Logistic analysis showed that, weight (OR = 0.906; 95% CI, 0.839-0.978; P = 0.011), baseline platelet count (OR = 0.989; 95% CI, 0.977-1.000; P = 0.049), C(min) (OR = 1.545; 95% CI, 1.203-1.983; P = 0.001), and APACHE II score (OR = 1.130; 95% CI, 1.003-1.273; P = 0.044) were significant factors for linezolid-associated thrombocytopenia. The area under the ROC curve of the combined predictor was larger based on the above factors. When the Youden index was the maximum, the best optimal cut-off point was 205.6 on the ROC curve; when C(min) ≥ 2 mg/L, the probability of bacterial eradication was more than 80%; when C(min) ≥ 6.3 mg/L, the probability of thrombocytopenia was more than 50 %. In clinical practice, when the calculating results of the combined predictor ≤205.6, the risk of the development of thrombocytopenia may be higher. Furthermore, maintenance of C(min) between 2 and 6.3 mg/L over time may be helpful in retaining appropriate efficacy and reducing the associated thrombocytopenia. More... »

PAGES

1029-1035

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-013-2041-3

DOI

http://dx.doi.org/10.1007/s10096-013-2041-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045769381

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24515096


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acetamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Critical Illness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linezolid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxazolidinones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ROC Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dong", 
        "givenName": "H.-Y.", 
        "id": "sg:person.01323621622.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323621622.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xie", 
        "givenName": "J.", 
        "id": "sg:person.0620112050.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620112050.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Central Intensive Care Unit, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "L.-H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "T.-T.", 
        "id": "sg:person.01024010174.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024010174.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Infectious Diseases, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "Y.-R.", 
        "id": "sg:person.01005407175.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005407175.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xi'an Jiaotong University", 
          "id": "https://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, 710061, Xi\u2019an, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dong", 
        "givenName": "Y.-L.", 
        "id": "sg:person.0654067210.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654067210.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1177/00912700122010294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000307627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.00177-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000886540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dkm431", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001464431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10156-010-0080-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004489563", 
          "https://doi.org/10.1007/s10156-010-0080-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.46.8.2723-2726.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009633430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diagmicrobio.2007.06.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010365858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200342150-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010581658", 
          "https://doi.org/10.2165/00003088-200342150-00007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200342150-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010581658", 
          "https://doi.org/10.2165/00003088-200342150-00007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dki202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014596263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2006.04.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017342811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/498509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018995503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e318218cf18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020210919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e318218cf18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020210919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e318218cf18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020210919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2008.07.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029022085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2010.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031831886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.01411-05", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033528072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00365548.2011.608712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036612658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.00247-07", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046039440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2009.10.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046816326"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/338403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049416075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000180580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051087304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dks153", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051883979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijantimicag.2011.05.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053144639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/eri.10.26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068080123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075006496", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-06", 
    "datePublishedReg": "2014-06-01", 
    "description": "To investigate the risk factors associated with the development of thrombocytopenia, and define the thresholds of efficacy and safety in critically ill patients who received linezolid therapy. A retrospective study was performed in critically ill patients treated with linezolid. Risk factors associated with thrombocytopenia were identified via medical records and trough levels (C(min)) measured during linezolid treatment. By establishing a logistic model, the risks were predicted by the receiver operating characteristic (ROC) curve and the thresholds of efficacy and safety were identified in the patients. Logistic analysis showed that, weight (OR\u2009=\u20090.906; 95% CI, 0.839-0.978; P\u2009=\u20090.011), baseline platelet count (OR\u2009=\u20090.989; 95% CI, 0.977-1.000; P\u2009=\u20090.049), C(min) (OR\u2009=\u20091.545; 95% CI, 1.203-1.983; P\u2009=\u20090.001), and APACHE II score (OR\u2009=\u20091.130; 95% CI, 1.003-1.273; P\u2009=\u20090.044) were significant factors for linezolid-associated thrombocytopenia. The area under the ROC curve of the combined predictor was larger based on the above factors. When the Youden index was the maximum, the best optimal cut-off point was 205.6 on the ROC curve; when C(min)\u2009\u2265\u20092 mg/L, the probability of bacterial eradication was more than 80%; when C(min)\u2009\u2265\u20096.3 mg/L, the probability of thrombocytopenia was more than 50 %. In clinical practice, when the calculating results of the combined predictor \u2264205.6, the risk of the development of thrombocytopenia may be higher. Furthermore, maintenance of C(min) between 2 and 6.3 mg/L over time may be helpful in retaining appropriate efficacy and reducing the associated thrombocytopenia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10096-013-2041-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "name": "Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients", 
    "pagination": "1029-1035", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "da04cf2d9bf635de000659b78d1996af310d407344da22ea67ae7bfa60c64ffc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24515096"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8804297"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-013-2041-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045769381"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-013-2041-3", 
      "https://app.dimensions.ai/details/publication/pub.1045769381"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s10096-013-2041-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-2041-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-2041-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-2041-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-013-2041-3'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      72 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-013-2041-3 schema:about N04842e8ffd18413d9a29ae89ead852ec
2 N350d9048a17f4f8b89c270ed364adbef
3 N42463c2b45a44faabe4a3727c2b8c78a
4 N4809db2b52ad4d90a6dd9484456042eb
5 N7ae89833bcdb48a1810cd1907417cf88
6 N7f9ccb5dba5f4a6a8d4257b57f6c781c
7 N80546ec30a0747af996ddfee5fd0397e
8 N8148f9e9c3314f62a70e00de030bcc0f
9 N899628e3164c4e2dbaa08e98450c115d
10 N8b063138356c4be0a9f333a29cd78e98
11 N92c90d5f3da348778680b8beea8ecd55
12 N93d717cc7a6746d39169efae079caa97
13 Nb090c5ffbd894456a3c51fe57e8fec88
14 Nb2324e7b41d441108eb40439c883ee62
15 Nbab910db430c4d1b90d5489cc3989a44
16 Nc029e1aa9e2a4895bfaab6489b607464
17 Nc444ef31b02141dd94fcde69ef3c06ae
18 Ndd8210f4f92a4734afcf15deab175c02
19 Ne29b38d04cff4e0b9246f919e04582d9
20 Ne925fb85daa346e7a37e497ad342e5e2
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N86681a71d7be451b810602b5223dafad
24 schema:citation sg:pub.10.1007/s10156-010-0080-6
25 sg:pub.10.2165/00003088-200342150-00007
26 https://app.dimensions.ai/details/publication/pub.1075006496
27 https://doi.org/10.1016/j.clinthera.2009.10.017
28 https://doi.org/10.1016/j.diagmicrobio.2007.06.001
29 https://doi.org/10.1016/j.ijantimicag.2006.04.017
30 https://doi.org/10.1016/j.ijantimicag.2008.07.002
31 https://doi.org/10.1016/j.ijantimicag.2010.02.019
32 https://doi.org/10.1016/j.ijantimicag.2011.05.007
33 https://doi.org/10.1086/338403
34 https://doi.org/10.1086/498509
35 https://doi.org/10.1093/jac/dki202
36 https://doi.org/10.1093/jac/dkm431
37 https://doi.org/10.1093/jac/dks153
38 https://doi.org/10.1097/maj.0b013e318218cf18
39 https://doi.org/10.1128/aac.00177-10
40 https://doi.org/10.1128/aac.00247-07
41 https://doi.org/10.1128/aac.01411-05
42 https://doi.org/10.1128/aac.46.8.2723-2726.2002
43 https://doi.org/10.1159/000180580
44 https://doi.org/10.1177/00912700122010294
45 https://doi.org/10.1586/eri.10.26
46 https://doi.org/10.3109/00365548.2011.608712
47 schema:datePublished 2014-06
48 schema:datePublishedReg 2014-06-01
49 schema:description To investigate the risk factors associated with the development of thrombocytopenia, and define the thresholds of efficacy and safety in critically ill patients who received linezolid therapy. A retrospective study was performed in critically ill patients treated with linezolid. Risk factors associated with thrombocytopenia were identified via medical records and trough levels (C(min)) measured during linezolid treatment. By establishing a logistic model, the risks were predicted by the receiver operating characteristic (ROC) curve and the thresholds of efficacy and safety were identified in the patients. Logistic analysis showed that, weight (OR = 0.906; 95% CI, 0.839-0.978; P = 0.011), baseline platelet count (OR = 0.989; 95% CI, 0.977-1.000; P = 0.049), C(min) (OR = 1.545; 95% CI, 1.203-1.983; P = 0.001), and APACHE II score (OR = 1.130; 95% CI, 1.003-1.273; P = 0.044) were significant factors for linezolid-associated thrombocytopenia. The area under the ROC curve of the combined predictor was larger based on the above factors. When the Youden index was the maximum, the best optimal cut-off point was 205.6 on the ROC curve; when C(min) ≥ 2 mg/L, the probability of bacterial eradication was more than 80%; when C(min) ≥ 6.3 mg/L, the probability of thrombocytopenia was more than 50 %. In clinical practice, when the calculating results of the combined predictor ≤205.6, the risk of the development of thrombocytopenia may be higher. Furthermore, maintenance of C(min) between 2 and 6.3 mg/L over time may be helpful in retaining appropriate efficacy and reducing the associated thrombocytopenia.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree false
53 schema:isPartOf N629e502d65a84d1896b8374ceb75d350
54 Nc98d7692e0d64ca2a03cae4170242845
55 sg:journal.1093599
56 schema:name Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
57 schema:pagination 1029-1035
58 schema:productId N03a6e24584614adfba7d1fcf2eee0d36
59 N3d3414f43c424a5fb8afe287739d58d0
60 N81d0378a124a4da9a461aec938c87d02
61 Ncb056e8c031d4648872a135c796c9ab5
62 Nd61fddd15a564e1a8c928f07ebffc727
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045769381
64 https://doi.org/10.1007/s10096-013-2041-3
65 schema:sdDatePublished 2019-04-10T19:04
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Nabf9a8f8d0844089bde04ab7749b9c0b
68 schema:url http://link.springer.com/10.1007/s10096-013-2041-3
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N03a6e24584614adfba7d1fcf2eee0d36 schema:name pubmed_id
73 schema:value 24515096
74 rdf:type schema:PropertyValue
75 N04842e8ffd18413d9a29ae89ead852ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Female
77 rdf:type schema:DefinedTerm
78 N350d9048a17f4f8b89c270ed364adbef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Adult
80 rdf:type schema:DefinedTerm
81 N390f165ecf024643b09123a4bd938d57 rdf:first sg:person.0620112050.03
82 rdf:rest N7696e3aa72354db5914b02642dc55aeb
83 N3d3414f43c424a5fb8afe287739d58d0 schema:name nlm_unique_id
84 schema:value 8804297
85 rdf:type schema:PropertyValue
86 N42463c2b45a44faabe4a3727c2b8c78a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Risk Factors
88 rdf:type schema:DefinedTerm
89 N4809db2b52ad4d90a6dd9484456042eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Anti-Bacterial Agents
91 rdf:type schema:DefinedTerm
92 N629e502d65a84d1896b8374ceb75d350 schema:volumeNumber 33
93 rdf:type schema:PublicationVolume
94 N7696e3aa72354db5914b02642dc55aeb rdf:first Nd15cd978fcff448cafbd02682e7f3cf3
95 rdf:rest Na34b3ff3eb5641d0b23d5a80b15622f8
96 N7820018b62d54a63badce3199558ba8c rdf:first sg:person.01005407175.28
97 rdf:rest N87aaa513b6ee448996346004182b7196
98 N7ae89833bcdb48a1810cd1907417cf88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Adolescent
100 rdf:type schema:DefinedTerm
101 N7f9ccb5dba5f4a6a8d4257b57f6c781c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Thrombocytopenia
103 rdf:type schema:DefinedTerm
104 N80546ec30a0747af996ddfee5fd0397e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Retrospective Studies
106 rdf:type schema:DefinedTerm
107 N8148f9e9c3314f62a70e00de030bcc0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N81d0378a124a4da9a461aec938c87d02 schema:name dimensions_id
111 schema:value pub.1045769381
112 rdf:type schema:PropertyValue
113 N86681a71d7be451b810602b5223dafad rdf:first sg:person.01323621622.38
114 rdf:rest N390f165ecf024643b09123a4bd938d57
115 N87aaa513b6ee448996346004182b7196 rdf:first sg:person.0654067210.33
116 rdf:rest rdf:nil
117 N899628e3164c4e2dbaa08e98450c115d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Oxazolidinones
119 rdf:type schema:DefinedTerm
120 N8b063138356c4be0a9f333a29cd78e98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged, 80 and over
122 rdf:type schema:DefinedTerm
123 N92c90d5f3da348778680b8beea8ecd55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name ROC Curve
125 rdf:type schema:DefinedTerm
126 N93d717cc7a6746d39169efae079caa97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Middle Aged
128 rdf:type schema:DefinedTerm
129 Na34b3ff3eb5641d0b23d5a80b15622f8 rdf:first sg:person.01024010174.17
130 rdf:rest N7820018b62d54a63badce3199558ba8c
131 Nabf9a8f8d0844089bde04ab7749b9c0b schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 Nb090c5ffbd894456a3c51fe57e8fec88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 Nb2324e7b41d441108eb40439c883ee62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Drug Monitoring
138 rdf:type schema:DefinedTerm
139 Nbab910db430c4d1b90d5489cc3989a44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Aged
141 rdf:type schema:DefinedTerm
142 Nc029e1aa9e2a4895bfaab6489b607464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Drug-Related Side Effects and Adverse Reactions
144 rdf:type schema:DefinedTerm
145 Nc444ef31b02141dd94fcde69ef3c06ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Linezolid
147 rdf:type schema:DefinedTerm
148 Nc98d7692e0d64ca2a03cae4170242845 schema:issueNumber 6
149 rdf:type schema:PublicationIssue
150 Ncb056e8c031d4648872a135c796c9ab5 schema:name readcube_id
151 schema:value da04cf2d9bf635de000659b78d1996af310d407344da22ea67ae7bfa60c64ffc
152 rdf:type schema:PropertyValue
153 Nd15cd978fcff448cafbd02682e7f3cf3 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
154 schema:familyName Chen
155 schema:givenName L.-H.
156 rdf:type schema:Person
157 Nd61fddd15a564e1a8c928f07ebffc727 schema:name doi
158 schema:value 10.1007/s10096-013-2041-3
159 rdf:type schema:PropertyValue
160 Ndd8210f4f92a4734afcf15deab175c02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Young Adult
162 rdf:type schema:DefinedTerm
163 Ne29b38d04cff4e0b9246f919e04582d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Critical Illness
165 rdf:type schema:DefinedTerm
166 Ne925fb85daa346e7a37e497ad342e5e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Acetamides
168 rdf:type schema:DefinedTerm
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
173 schema:name Clinical Sciences
174 rdf:type schema:DefinedTerm
175 sg:journal.1093599 schema:issn 0934-9723
176 1435-4373
177 schema:name European Journal of Clinical Microbiology & Infectious Diseases
178 rdf:type schema:Periodical
179 sg:person.01005407175.28 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
180 schema:familyName Zhao
181 schema:givenName Y.-R.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005407175.28
183 rdf:type schema:Person
184 sg:person.01024010174.17 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
185 schema:familyName Wang
186 schema:givenName T.-T.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024010174.17
188 rdf:type schema:Person
189 sg:person.01323621622.38 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
190 schema:familyName Dong
191 schema:givenName H.-Y.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323621622.38
193 rdf:type schema:Person
194 sg:person.0620112050.03 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
195 schema:familyName Xie
196 schema:givenName J.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620112050.03
198 rdf:type schema:Person
199 sg:person.0654067210.33 schema:affiliation https://www.grid.ac/institutes/grid.43169.39
200 schema:familyName Dong
201 schema:givenName Y.-L.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654067210.33
203 rdf:type schema:Person
204 sg:pub.10.1007/s10156-010-0080-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004489563
205 https://doi.org/10.1007/s10156-010-0080-6
206 rdf:type schema:CreativeWork
207 sg:pub.10.2165/00003088-200342150-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010581658
208 https://doi.org/10.2165/00003088-200342150-00007
209 rdf:type schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1075006496 schema:CreativeWork
211 https://doi.org/10.1016/j.clinthera.2009.10.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046816326
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.diagmicrobio.2007.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010365858
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.ijantimicag.2006.04.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017342811
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.ijantimicag.2008.07.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029022085
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/j.ijantimicag.2010.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031831886
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.ijantimicag.2011.05.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053144639
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1086/338403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049416075
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1086/498509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018995503
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1093/jac/dki202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014596263
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1093/jac/dkm431 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001464431
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1093/jac/dks153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051883979
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1097/maj.0b013e318218cf18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020210919
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1128/aac.00177-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000886540
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1128/aac.00247-07 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046039440
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1128/aac.01411-05 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033528072
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1128/aac.46.8.2723-2726.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009633430
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1159/000180580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051087304
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1177/00912700122010294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000307627
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1586/eri.10.26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068080123
248 rdf:type schema:CreativeWork
249 https://doi.org/10.3109/00365548.2011.608712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036612658
250 rdf:type schema:CreativeWork
251 https://www.grid.ac/institutes/grid.43169.39 schema:alternateName Xi'an Jiaotong University
252 schema:name Central Intensive Care Unit, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, 710061, Xi’an, China
253 Department of Infectious Diseases, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, 710061, Xi’an, China
254 Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, 710061, Xi’an, China
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...